$BLUE won FDA approval for Zynteglo, a gene therapy for beta thalassemia patients dependent on regular blood transfusions. investor.bluebirdbio.com/news-releases/…

Wow! Geoffrey Porges left SVB. I wondered why I hadn't seen his emails in a while. endpts.com/longtime-analy…

$AXSM is up 34% right now after winning FDA approval for its depression treatment. I recently wrote about the late-stage pipeline in depression. investors.com/news/technolog…

The White House is preparing to transfer financial responsibility for Covid shots and treatments to consumers. $PFE $MRNA $BNTX $MRK $GILD $JNJ $NVAX investors.com/news/technolog…

Hey, look at pharma staying in the green!

Much to the horror of my husband, I taught the twins how to knock on doors. But I didn't teach them to stop when someone doesn't answer. 🤣

Tell me, Internet, is soy cheese worth it? Or will it just make me sad?

$AXSM surges after winning FDA approval for a new depression drug. It's an oral NMDA receptor agonist, the first of its kind. investors.com/news/technolog…

In June, we shared that we are developing a bivalent Omicron BA.4/BA.5-adapted vaccine. I’m excited to update that we completed our EUA submission to U.S. FDA today, and plan to complete our EMA submission in the coming days: on.pfizer.com/3QXMg6T

$PHVS tumbled on bad news for its hereditary angioedema programs. Read on here: investors.com/news/technolog…

Me finishing "Fox in Socks" without stuttering once is the closest I'll ever be to becoming a rapper.

My husband and I almost had a collective panic attack watching this. (I had some childbirth complications.) The word "torture" is apt. I used that word to describe this scene after watching it.

Highly rated $SGFY and $PRVA surged today on news $AMZN, $UNH, $CVS and $OPCH. investors.com/news/technolog…

When you email a PR person ENDLESSLY about a specific topic... only to see him quoted in another publication about said topic (after ghosting you for a month). Yes, this is a subtweet. Yes, I'm bitter.

Two of the best-rated biotech stocks are also among the worst performers today. Here's why. $APLS $BLTE investors.com/news/technolog…